Cargando…

Treatment patterns in pediatric patients with multiple sclerosis in Germany—a nationwide claim-based analysis

BACKGROUND: The manifestation of multiple sclerosis (MS) in childhood and adolescence occurs in 3%−5% of all MS cases. However, the immunomodulatory and symptomatic treatment options in this population group are still limited. OBJECTIVE: We aimed to elucidate the prescription frequency of medication...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frahm, Niklas, Peters, Melanie, Bätzing, Jörg, Ellenberger, David, Akmatov, Manas K., Haas, Judith, Rommer, Paulus S., Stahmann, Alexander, Zettl, Uwe K., Holstiege, Jakob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504210/ https://www.ncbi.nlm.nih.gov/pubmed/34646362 http://dx.doi.org/10.1177/17562864211048336

Ejemplares similares

Trends and regional distribution of outpatient claims for asthma, 2009–2016, Germany
por: Akmatov, Manas K, et al.
Publicado: (2020)

Secular Trends and Rural–Urban Differences in Diagnostic Prevalence of Hay Fever: A Claims-Based Study in Germany
por: Akmatov, Manas K, et al.
Publicado: (2022)

Secular trends and regional variations in pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents in Germany
por: Akmatov, Manas K., et al.
Publicado: (2021)

The Effect of the COVID-19 Pandemic on Outpatient Antibiotic Prescription Rates in Children and Adolescents—A Claims-Based Study in Germany
por: Akmatov, Manas K., et al.
Publicado: (2022)

Epileptic seizures at multiple sclerosis onset and their role in disease progression
por: Grothe, Matthias, et al.
Publicado: (2023)

Trends in incidence of atopic disorders in children and adolescents - Analysis of German claims data
por: Kohring, Claudia, et al.
Publicado: (2023)

Aggressive multiple sclerosis: a matter of measurement and timing
por: Ellenberger, David, et al.
Publicado: (2020)

Marked reductions in outpatient antibiotic prescriptions for children and adolescents – a population-based study covering 83% of the paediatric population, Germany, 2010 to 2018
por: Holstiege, Jakob, et al.
Publicado: (2020)

Patterns of the initiation of disease-modifying antirheumatic drugs in incident rheumatoid arthritis: a German perspective based on nationwide ambulatory drug prescription data
por: Steffen, Annika, et al.
Publicado: (2018)

Comorbidity profile of patients with concurrent diagnoses of asthma and COPD in Germany
por: Akmatov, Manas K., et al.
Publicado: (2020)

Epidemiology of Lyme borreliosis based on outpatient claims data of all people with statutory health insurance, Germany, 2019
por: Akmatov, Manas K, et al.
Publicado: (2022)

Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care
por: Jalusic, Kris Oliver, et al.
Publicado: (2021)

Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry
por: Frahm, Niklas, et al.
Publicado: (2022)

Relapsing and progressive MS: the sex-specific perspective
por: Rommer, Paulus Stefan, et al.
Publicado: (2020)

Management of MS Patients Treated With Daclizumab – a Case Series of 267 Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study
por: Frahm, Niklas, et al.
Publicado: (2022)

Patients at high risk for a severe clinical course of COVID-19 — small-area data in support of vaccination and other population-based interventions in Germany
por: Holstiege, Jakob, et al.
Publicado: (2021)

Diabetes mellitus and comorbidities – A cross-sectional study with control group based on nationwide ambulatory claims data
por: Schmidt, Christian, et al.
Publicado: (2021)

Mental and somatic comorbidity of depression: a comprehensive cross-sectional analysis of 202 diagnosis groups using German nationwide ambulatory claims data
por: Steffen, Annika, et al.
Publicado: (2020)

Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study
por: Frahm, Niklas, et al.
Publicado: (2023)

Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson Disease
por: Schrag, Anette, et al.
Publicado: (2022)

Trends and regional variations in the administrative prevalence of attention-deficit/hyperactivity disorder among children and adolescents in Germany
por: Akmatov, M. K., et al.
Publicado: (2018)

Application of Statistical Methods for Central Statistical Monitoring and Implementations on the German Multiple Sclerosis Registry
por: Fneish, Firas, et al.
Publicado: (2023)

Coping behavior in multiple sclerosis—complementary and alternative medicine: A cross‐sectional study
por: Rommer, Paulus S, et al.
Publicado: (2018)

Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry
por: Ohle, Lisa-Marie, et al.
Publicado: (2021)

Polypharmacy in patients with multiple sclerosis: a gender-specific analysis
por: Frahm, Niklas, et al.
Publicado: (2019)

Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study
por: Frahm, Niklas, et al.
Publicado: (2019)

Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors
por: Frahm, Niklas, et al.
Publicado: (2019)

Effects of normobaric hypoxic endurance training on fatigue in patients with multiple sclerosis: a randomized prospective pilot study
por: Zrzavy, Tobias, et al.
Publicado: (2021)

Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis
por: Hecker, Michael, et al.
Publicado: (2021)

Vaccination in Multiple Sclerosis: Friend or Foe?
por: Zrzavy, Tobias, et al.
Publicado: (2019)

Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients—A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness
por: Ehler, Johannes, et al.
Publicado: (2017)

Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
por: Monschein, Tobias, et al.
Publicado: (2021)

The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
por: Frahm, Niklas, et al.
Publicado: (2020)

Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic
por: Heidler, Felicita, et al.
Publicado: (2022)

Nationwide Incidence of Normal Pressure Hydrocephalus (NPH) Assessed by Insurance Claim Data in Germany
por: Lemcke, Johannes, et al.
Publicado: (2016)

Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis
por: Baldt, Julia, et al.
Publicado: (2023)

Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 1: Empfehlungen
por: Monschein, Tobias, et al.
Publicado: (2021)

Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 2: Impfstofftechnologien
por: Monschein, Tobias, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i8n3up0qrlp5thu8fuvqo0gjah